ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 6, 2020

Primary Completion Date

October 3, 2023

Study Completion Date

November 15, 2023

Conditions
Clostridium Difficile Infection
Interventions
DRUG

Ibezapolstat

Investigational antibacterial agent

DRUG

Vancomycin

Active comparator

Trial Locations (29)

11758

Acurx Site #130: Dr Michael DiGiovanna, North Massapequa

22031

Acurx Site #106: Dr Bezawit Tekola, Fairfax

24501

Acurx Site #109: Dr Robert Brennan, Lynchburg

27103

Acurx Site #127: Dr Christopher Connolley, Winston-Salem

29572

Acurx Site #126: Dr Andrew Pearson, Myrtle Beach

32405

Acurx Site #117: Dr Rafael Companioni, Panama City

33015

Acurx Site #101: Dr Idalia Acosta, Miami

33125

Acurx Site #124: Dr Yunior Silva-Barrero, Miami

33142

Acurx Site #108: Dr Idania Garcia Del Sol, Miami

33155

Acurx Site #116: Dr Erick Juarez, Miami

33166

Acurx Site #105, Doral

Acurx Site #107: Dr Belkis Delgado, Miami Springs

33172

Acurx Site #122: Dr Faride Ramos, Doral

33186

Acurx Site #119: Dr Jorge Paoli-Bruno, Miami

37404

Acurx Site #114: Dr Eugene Ryan, Chattanooga

59701

Acurx Site #103: Dr John Pullman, Butte

76508

Acurx Site #113: Dr Jennifer Vincent, Temple

76550

Acurx Site #120: Dr Vanna Gold, Lampasas

77024

Acurx Site #121: Dr Ramesh Gowrappala, Houston

83404

Acurx Site #102: Dr Richard Nathan, Idaho Falls

84010

Acurx Site #110: Dr Val Hansen, Bountiful

85251

Acurx Site #118: Dr Janet Reiser, Scottsdale

92262

Acurx Site #131: Dr Michael Jardula, Palm Springs

92307

Acurx Site #115: Dr Neera Grover, Apple Valley

93012

Acurx Site #125: Dr Karen Simon, Camarillo

93534

Acurx Site #111: Dr Jatinder Pruthi, Lancaster

95817

Acurx Site #129: Dr Stuart Cohen, Sacramento

02462

Acurx Site #123: Dr Harry Schrager, Newton

01655

Acurx Site #104: Dr JeanMarie Houghton, Worcester

Sponsors
All Listed Sponsors
lead

Acurx Pharmaceuticals Inc.

INDUSTRY

NCT04247542 - ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection | Biotech Hunter | Biotech Hunter